IM
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
4.23
Exchange
XNAS - Nasdaq
-0.047 B
Last period FCFE ,USD
-662%
FCFE has decreased in 4 years
What is FCFE ?
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
See also Immunovant
Company Analysis
IMVT valuation, rating, competitors, insights and company profile
Eyestock Rating
IMVT financial analysis by Eyestock methodology
Valuation
IMVT valuation using historical relative method
Statements
IMVT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
IMVT dividend yield and annual dividend
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
Immunovant`s FCFE for the period ended 2023-12-31 is -0.047 B USD
